相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Adaptation to mTOR kinase inhibitors by amplification of eIF4E to maintain cap-dependent translation
Claire L. Cope et al.
JOURNAL OF CELL SCIENCE (2014)
Genetic inactivation or pharmacological inhibition of Pdk1 delays development and inhibits metastasis of BrafV600E::Pten-/- melanoma
M. Scortegagna et al.
ONCOGENE (2014)
Genetic and Pharmacologic Inhibition of mTORC1 Promotes EMT by a TGF-β-Independent Mechanism
Ivan Mikaelian et al.
CANCER RESEARCH (2013)
Current Status and Future Perspectives of PI3K and mTOR Inhibitor as Anticancer Drugs in Breast Cancer
Xiaobei Zhang et al.
CURRENT CANCER DRUG TARGETS (2013)
Mechanistic Target of Rapamycin Complex 1 (mTORC1)-mediated Phosphorylation Is Governed by Competition between Substrates for Interaction with Raptor
Michael D. Dennis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
mTORC1 Inhibition Is Required for Sensitivity to PI3K p110α Inhibitors in PIK3CA-Mutant Breast Cancer
Moshe Elkabets et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
How cancer metabolism is tuned for proliferation and vulnerable to disruption
Almut Schulze et al.
NATURE (2012)
3-Phosphoinositide-Dependent Kinase 1 Controls Breast Tumor Growth in a Kinase-Dependent but Akt-Independent Manner
Paolo Armando Gagliardi et al.
NEOPLASIA (2012)
PDK1 Attenuation Fails to Prevent Tumor Formation in PTEN-Deficient Transgenic Mouse Models
Katharine Ellwood-Yen et al.
CANCER RESEARCH (2011)
Targeting PI3K/mTOR Signaling in Cancer
Brooke M. Emerling et al.
CANCER RESEARCH (2011)
mTORC1 and mTORC2 Regulate EMT, Motility, and Metastasis of Colorectal Cancer via RhoA and Rac1 Signaling Pathways
Pat Gulhati et al.
CANCER RESEARCH (2011)
Genetic and Pharmacological Inhibition of PDK1 in Cancer Cells CHARACTERIZATION OF A SELECTIVE ALLOSTERIC KINASE INHIBITOR
Kumiko Nagashima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Regulation of cancer cell metabolism
Rob A. Cairns et al.
NATURE REVIEWS CANCER (2011)
Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimus
Federica Di Nicolantonio et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Triple-negative breast cancer
Reinaldo D. Chacon et al.
BREAST CANCER RESEARCH (2010)
3-Phosphoinositide-Dependent Kinase 1 Potentiates Upstream Lesions on the Phosphatidylinositol 3-Kinase Pathway in Breast Carcinoma
Matthew Maurer et al.
CANCER RESEARCH (2009)
In vivo Antitumor Activity of MEK and Phosphatidylinositol 3-Kinase Inhibitors in Basal-Like Breast Cancer Models
Klaus P. Hoeflich et al.
CLINICAL CANCER RESEARCH (2009)
Down-Regulation of 3-Phosphoinositide-Dependent Protein Kinase-1 Levels Inhibits Migration and Experimental Metastasis of Human Breast Cancer Cells
Ying Liu et al.
MOLECULAR CANCER RESEARCH (2009)
PDK1 coordinates survival pathways and β-adrenergic response in the heart
Kaoru Ito et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Comprehensive identification of PIP3-regulated PH domains from C elegans to H sapiens by model prediction and live imaging
Wei Sun Park et al.
MOLECULAR CELL (2008)
Cell size and invasion in TGF-β-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway
Samy Lamouille et al.
JOURNAL OF CELL BIOLOGY (2007)
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
P. J. Roberts et al.
ONCOGENE (2007)
Polyoma and SV40 proteins differentially regulate PP2A to activate distinct cellular signaling pathways involved in growth control
Pablo Rodriguez-Viciana et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Current development of mTOR inhibitors as anticancer agents
Sandrine Faivre et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
3-Phosphoinositide-dependent Protein Kinase-1 (PDK1) promotes invasion and activation of matrix metalloproteinases
Zhihui Xie et al.
BMC CANCER (2006)
TOR signaling in growth and metabolism
S Wullschleger et al.
CELL (2006)
Complex networks orchestrate epithelial-mesenchymal transitions
JP Thiery et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
TOR signaling in growth and metabolism
Stephan Wullschleger et al.
CELL (2006)
Elevated phosphorylation and activation of PDK-I/AKT pathway in human breast cancer
HJ Lin et al.
BRITISH JOURNAL OF CANCER (2005)
Exploiting the PI3K/AKT pathway for cancer drug discovery
BT Hennessy et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Perturbations of the AKT signaling pathway in human cancer
DA Altomare et al.
ONCOGENE (2005)
Uptake of a fluorescent deoxyglucose analog (2-NBDG) in tumor cells
RG O'Neil et al.
MOLECULAR IMAGING AND BIOLOGY (2005)
Hypomorphic mutation of PDK1 suppresses tumorigenesis in PTEN+/- mice
JR Bayascas et al.
CURRENT BIOLOGY (2005)
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
DD Sarbassov et al.
SCIENCE (2005)
High frequency of mutations of the PIK3CA gene in human cancers
Y Samuels et al.
SCIENCE (2004)
Global expression profiling identifies signatures of tumor virulence in MMTV-PyMT-transgenic mice: Correlation to human disease
TH Qiu et al.
CANCER RESEARCH (2004)
Deficiency of PDK1 in cardiac muscle results in heart failure and increased sensitivity to hypoxia
A Mora et al.
EMBO JOURNAL (2003)
Regulation of an activated S6 kinase 1 variant reveals a novel mammalian target of rapamycin phosphorylation site
M Saitoh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
分享论文
